Global Microbial Protein Market

Microbial Protein Market Size, Share, Growth Analysis, By Type(Algae, Bacteria, Yeast, Fungi), By Application(Dietary nutrition, functional nutrients, sports nutrition, infant nutrition), By Region - Industry Forecast 2024-2031


Report ID: SQSG30I2037 | Region: Global | Published Date: July, 2036
Pages: 165 | Tables: 66 | Figures: 75

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Microbial Protein Market size was valued at USD 44.3 million in 2019 and is poised to grow from USD 47.3 million in 2023 to USD 76.8 million by 2031, growing at a CAGR of 6.7% in the forecast period (2024-2031).

The microbial protein market is highly fragmented, with numerous small and medium-sized companies as well as new entrants penetrating the market. Over the last 4 to 5 years, these businesses have employed a variety of tactics to extend their product and service offerings, worldwide footprints, and market shares. Most firms in the microbial protein industry used agreements, collaborations, partnerships, new product launches, expansions, mergers, acquisitions, and joint ventures as significant tactics. 'Novozymes', 'DSM', 'Dupont', 'Lallemand', 'Lesaffre', 'Archer Daniels Midland', 'Cargill', 'Corbion', 'Alltech', 'Calysta', 'Unibio', 'Fermic', 'BioProcess Algae', 'Algenuity', 'Solazyme', 'Green Biologics', 'Kiverdi', 'Blue Marble Biomaterials', 'Synbio Technologies', 'Ginkgo Bioworks'

Spirulina protein gaining traction

Microbial protein is a highquality protein source that can substitute animal protein such as fishmeal in livestock feeding and aquaculture. Moving up the food chain, microbial protein meets the FAO/WHO requirements for essential amino acid scoring patterns in human nutrition, and hence people could benefit considerably from the use of MP directly as food. Fungi are another viable option that has made their way into human cuisine. QuornTM is the most successful example of mycoprotein, having been commercialized and sold in over 15 countries across the world. Mycoproteins are particularly well suited to mimicking the flavor and consistency of meat, which explains their popularity as an alternative to traditional animal-based goods. Currently, mycoprotein production for QuornTM product manufacture totals 25,000 tons per year, with a global market value of around 214 million Euro, and is expected to rise at a rate of 20% per year in the next years.

The Microbial Protein market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to account for the largest share of the microbial protein market by 2022. The prominent position of North America in the Microbial Protein market is attributed to the increasing focus on producing protein using sustainable methods due to rising environmental concerns and ethical aspects associated with animal protein, the increasing vegan population, the increasing number of investments in microbial protein products, the increasing demand for healthy & nutritional products, and technological advancements in the food industry. During the forecast period, Asia-Pacific is expected to have the highest CAGR. The rapid expansion of this regional market is primarily due to increased awareness of the benefits of protein-rich diets, technical advancements in the food and beverage industry, a fast-growing economy, and a wide availability of raw materials.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Microbial Protein Market

Report ID: SQSG30I2037

$5,300
BUY NOW GET FREE SAMPLE